全国免费服务热线:021-64330607 服务时间 9:00-22:00 新浪微博 腾讯微博 注册 当前用户:[USERNAME],用户ID:[USERID] 用户中心 退出 收藏本页

bju international

来源:作者:热度:Loading...日期:2014-01-23, 08:35 PM

期刊名称 bju international 

期刊缩写 BJU INT   
学科分类 医学 

出版周期 半月刊   
审稿速度 1 个月 (平均) 

投稿命中率 25 % (均值)   
期刊主页 http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1464-410X   
ISSN 号 (printed): 1464-4096 (electronic): 1464-410X   
IF 趋势      2005     2006      2007       2008      2009     2010     2011     2012   
                2.247    2.635      2.751      2.704      2.865     3.19     2.844    3.046   
被收录情况   1. Science Citation Index 
                    2. Science Citation Index Expanded 
                    3. Current Contents - Clinical Medicine 
                    4. BIOSIS Previews   
PubSci评语 审稿速度较快。一审在一个月左右。专注于泌尿学领域,偏临床。彩页免费。开放获取形式需要额外交纳3000美元。   
期刊简介 BJUI是一个专注于泌尿学领域的国际期刊,提供泌尿学领域最新和最高水平的基础和临床信息。接收的论文包括成人级小儿泌尿外科领域的原创性研究论文、综述、评论及教育性文章。具体领域包括:泌尿系统肿瘤(泌尿肿瘤学的各个领域及诊断技术的最新进展)、机器人和腹腔镜手术、上尿路、功能性泌尿外科、性医学、儿科、转化科学、外科教育等。   
投稿注意事项 特别提醒:彩页免费。通过Open Access形式发表论文,需要交纳3000美元。
一般注意事项:
Author Guidelines
Download the PDF Author Guidelines.
Download the list of accepted abbreviations.
Download the Ethical Policies of the Journal.
The Editor of BJUI welcomes original contributions on topics of interest and importance to urologists, whether written by urologists, nephrologists, radiologists, nurses or basic scientists. We are able to offer fast publication and encourage colour illustrations wherever appropriate.
EDITORIAL POLICIES AND PROCEDURES
Submission and Peer-review
Submissions are considered on the conditions that they are previously unpublished, and are not offered simultaneously elsewhere; that all authors have read and approved the content; that all authors have declared all competing interests; and that the work complies with the Ethical Policies of the Journal, and has been conducted under internationally accepted ethical standards after relevant ethical review. It is imperative that authors read this policy and complete any necessary documentation prior to your submission. When submitting a manuscript it is with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and has not been submitted elsewhere for consideration for print or electronic publication.
This journal employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.
The journal operates a stringent peer review process. All manuscripts will be reviewed by the Editors, members of the Editorial Board, or other expert reviewers. At the discretion of the Editors, a manuscript may be returned immediately without full review, if deemed not competitive (for originality and quality) or outside the realm of interests of the majority of the readership of the Journal. Any statistical analyses will be assessed by a statistician. The decision (reject, revision, accept) letter will be conveyed through BJUI ScholarOne Manuscripts, coming directly from the Associate Editor who has assumed responsibility for the manuscript's review. If revision is requested, whether major or minor, the revised manuscript must be returned within two months. If it is not submitted within this time frame, it will be treated as a new submission and may be sent out for review to different reviewers. Editorial decisions are based not just on technical merit of the work, but also on other factors such as the priority for publication and the relevance to the Journal's general readership. All papers are judged in relation to other submissions currently under consideration. Acceptance of papers is based on the originality of the observation or investigation; the quality of the work described; the clarity of presentation; and the relevance to our readership. Rebuttals to rejected manuscripts are strongly discouraged and requests for resubmission of rejected manuscripts are generally not granted.
Publication Ethics
BJUI is a member of the Committee on Publication Ethics and subscribes to its recommendations (Committee on Publication Ethics [COPE]: guidelines on good publication practice, www.publicationethics.org.uk). Best Practice Guidelines on Publication Ethics are also available from http://www.blackwellpublishing.com/publicationethics/ (Graf C, Wager E, Bowman A, et al., Int J Clin Pract 2007; 61 [suppl 152]: 126). The Editors reserve the right to reject a paper on ethical grounds. All authors are responsible for adhering to guidelines on good publication practice.
PREPARATION OF MANUSCRIPTS
ARTICLE CATEGORIES
Original articles will be published under the headings below, and authors will be asked to indicate their preferred category upon submission: Urological Oncology; Robotics and Laparoscopy; Upper Urinary Tract; Functional Urology; Sexual Medicine; Paediatrics; Translational Science.
ARTICLE TYPES
Reviews are only commissioned by the Editor. These should be 2500-5000 words long, with up to 50 references and an abstract including up to 5 bullets of key messages.
Comments should be 800-1000 words, with up to 6 references.
Original Articles on clinical and scientific aspects of urology and its associated specialities should be no more than 4000 words (word count excludes figures, tables, references and abstract) with no limit on references, and include the following:
a. An abstract, sub-divided into:
Objective (which must start with 'To...' and be followed by a simple statement of the objectives, with no discursive material); Subjects/patients (or materials) and methods; Results; and Conclusion.
b. A list of 3-6 key words
c. Text, subdivided into: Introduction; Subjects/patients (or materials) and methods; Results; Discussion; Acknowledgements; References
d. Legends to illustrations
e. Tables and their legends.
Please ensure that any Tables and Figures are cited in the text.
Translational Science Section
The Editor and Associate Editors of the Translational Science section of BJUI are committed to publishing the highest quality scientific and translational papers following peer-review. To help authors pre-review their potential papers we recommend that you consider the following criteria:
1. High priority will be given to:
- translational studies with appropriate rationale and selection of in vitro and in vivo models
- papers with an insight into the mechanisms of action of initial observations.
2. Lower priority will be given to studies that:
- are observational with no information relevant to disease pathogenesis or mechanisms of action
- only use one cell line or model system - are largely confirmatory in a well-established body of research
- are not supported by robust and appropriate statistical analysis.
Surgical Education Original articles on topics including simulation, health services research, leadership and other non-technical skills.
Step-by-Step Brief articles (no more than one printed page) describing a surgical procedure in a series of clear steps, to accompany a high quality narrated surgical video, of up to 3 minutes length, which describes the technique in clear steps.
Letters Letters to the Editor are being phased out of the main BJUI journal, but we will continue to publish them on the BJUI website as an important part of the scientific debate.
Letters to the editor will now published in electronic form on the journal website (www.bjui.org), not in the journal itself. As such, letters are not submitted to PubMed for indexing.
Letters to the editor should be 500 words or less, preference is given to concise letters.
Writers are limited to one letter published on the website per month.
Letters must include full author contact details.
All letters will be peer-reviewed, and we reserve the right to reject letters, or to edit them if they are accepted.
If accepted, letters are sent to the authors of the paper being discussed, to give them the chance to make a response that will (if accepted) be published at the same time as the letter.
Letters will not be open for public comment; replies must be submitted to the Editorial Officefor review.
FORMAT
All manuscripts should start with a title page detailing: (1) the title of the article, (2) initials and names of each author, and (3) the name(s) of their institution(s). Correspondence during submission will be with the submitting author. All authors should be listed with their institutions on the title page of the manuscript. A correct e-mail address for all authors is essential. A covering letter should be included with the submission and should confirm that the paper has not been submitted elsewhere.
References
These should conform to the Vancouver style. The references in the text should be numbered consecutively in the order in which they appear and indicated by Arabic numerals in parentheses, e.g. [1]. If there are six or fewer authors, all should be listed. If there are more than six, then the first three should be listed followed by et al.
Examples:
1. Hall SA, Link CL, Hu JC, Eggers PW, McKinlay JB. Drug treatment of urological symptoms: esitmating the magnitude of unmet need in a community-based sample. BJU Int. 2009 104(11):160-8.
2. Wright FS, Howards SS. Obsctructive injury. In Bremner BM, Rector FC eds, The Kidney, 2nd edn, Vol.II. Chapt 38. Philadelphia: Saunders, 1981: 2009-44.
- References to unpublished work, including papers in preparation, should be kept to a minimum and should be mentioned in parentheses in the text as unpublished work, not in the reference list. The names of all contributors to the work should be given. - Unpublished observations, personal communications and abstracts published only in proceedings of meetings should be quoted within the text of the manuscript, in parentheses. Information from manuscripts submitted but not yet accepted should be cited in the text as unpublished observations.
Illustrations
Where possible, please provide high quality digital artwork files (seehttp://authorservices.wiley.com/prep_illust.asp). Magnification should be given with a scale bar or in the legend; magnification values in caption should be correct for enlgargement/ reduction of the illustration. Figures or tables reproduced from a published work must have the original source quoted and the permission of the copyright holder. Colour figures may be submitted and will be published free of charge. All histological illustrations should be supplied in colour. Authors wishing any submitted material (e.g. slides) to be returned should clearly identify as such.
Units/ Abbreviations
Authors should follow the SI system if units (except for blood pressure which will be continued to be expressed in mmHg) (Grange RI. BJU. 1996; 78:961-63). Numbers are written in full to nine; numerals are used from 10 upwards. Authors should limit their use of abbreviations and they should be used consistently throughout the text (see Abbreviations list at the end of each issue).
VIDEOS
Submission Videos may only be submitted to accompany a manuscript, videos received without a manuscript submission will not be considered. If your article includes a video/s, please state this in your covering letter. Ideally, videos should be uploaded when you submit your manuscript, and designated as a 'Supplementary File'. If this is not possible, or if a video is produced after your manuscript is accepted, please contact the Editorial Office to arrange to share the video file/s with us using Dropbox or FTP transfer. It is recommended that you submit two videos, a long and a short version. The short version should be no more than 2 minutes long focussing on the main procedure, if surgery related.
Formats/ file types We will accept digital files in MPG4, MP4, MOV and WMV formats. Combined files of a manuscript, including video, tables, figures and text must not exceed 100MB.
Content Contributors are asked to be succinct, and the Editors reserve the right to require shorter video duration. Legends for the video segments should be placed at the end of the article. The video should be high quality (both in content and visibility). The video should make a specific point; particularly, it should demonstrate the features described in the text of the manuscript. In addition, the content of the video sequence should directly follow the content of the video legend.The content of the video should not display overt product advertising. Educational presentations are encouraged.
Patient Consent The corresponding author must confirm in the Exclusive Licence Agreement (ELA) that he or she has received a signed release form from each patient videotaped authorizing the offline and/or online distribution of this video material. Videos will not be sent out for review until the signed ELA has been received. Ideally patients should not be identifiable from the video.
Publication The video will be hosted on BJUI.org the same day as the manuscript is published. A reference link to the video will be provided.
The Editors reserve the right to request additional video editing by the authors (which may delay publication) and to edit video submissions prior to posting and/or distribution, including the insertion of a voice-over by the Editor.
SUPPORTING INFORMATION
Online Supporting Information can include additional explanatory notes, data sets, lists, figures or tables that will not be published in the print edition of the journal and which are ancillary to, rather than central to, the article. Supporting Information must be approved by the Editor and will be published exactly as supplied, so it is the author's responsibility to ensure that the material is clearly laid out, adequately described, and in a format accessible to readers. Figures and tables in Supporting Information should be referred to in the main text and labelled Figure S1, Figure S2, or Table S1, etc., in the order cited. Full guidelines and information on acceptable file formats may be found at: http://authorservices.wiley.com/bauthor/suppmat.asp.
SUBMISSION
Submit your contribution online at http://mc.manuscriptcentral.com/bjui. You will need your entire manuscript and any supporting files in electronic format, and full names and correct email addresses for all authors. Full instructions, and the required user ID and password can be obtained by visiting the site. Support is provided through the 'Get Help Now' function of the site, by e-mailing support@scholarone.com or the Editorial Office editorial.office@bjui.info.
Authors unable to submit their manuscript online should contact the Editorial Office.
FORMS
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.aspand visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:
Creative Commons Attribution License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.aspand visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

Conflicts of Interest: BJUI employs the ICMJE conflicts of interest disclosure form. All corresponding authors will need to collect and keep on file ICMJE COI forms from each co-author, and add a full Conflicts of Interest statement to their manuscript that includes everything stated on the ICMJE COI forms for each co-author and themselves.
OPEN ACCESS POLICY
ONLINEOPEN
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee (currently $3000) to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see:http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms.
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at: https://onlinelibrary.wiley.com/onlineOpenOrder
Prior to acceptance there is no requirement to inform the Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the Journal's standard peer-review process and will be accepted or rejected based on their own merit.
NOTE TO NIH GRANTEES
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information seewww.wiley.com/go/nihmandate.
HINARI
Free online access to the Journal is available within institutions in the developing world through the HINARI initiative with the World Health Organization (WHO).
AUTHOR SERVICES
Free access to the final PDF offprint of your article will be available via Author Services only. Please therefore sign up for Author Services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers. Please visithttp://authorservices.wiley.com/bauthor for more information.
Proofs
The corresponding author will receive an e-mail alert containing a link to a secure website where the proof can be downloaded as an Acrobat PDF file. A working e-mail address must therefore be provided for the corresponding author. In the absence of the corresponding author, please arrange for a colleague to access the e-mail to retrieve the proofs. Corrections should be returned within three days of receipt to the Production Editor. Corrections should be kept to a minimum. Extensive changes may be charged to the author.
AUTHOR MATERIAL ARCHIVE POLICY
Wiley-Blackwell will dispose of all hard copy or electronic material submitted, two months after publication. If you require the return of any material submitted, please inform the Production Editor (bju@wiley.com) as soon as possible.   
编辑部信息 所在地:  国家 英国   
  Editor-in-Chief
Prokar Dasgupta
 
COI disclosure form
Associate Editors
Matthew Bultitude (Web) - COI disclosure form
Ben Challacombe (Innovation) - COI disclosure form
John Davis (Urological Oncology) - COI disclosure form
Dirk DeRidder (Benign Diseases) - COI disclosure form
Vincenzo Ficarra (Impact) - COI disclosure form not yet received
Roger Kirby (Editorials & Comments) - COI disclosure form
Declan Murphy (Social Media) - COI disclosure form
Alan Partin (Oncology) - COI disclosure form
Quoc-Dien Trinh (Health Services Research) - COI disclosure form
Alan Wein (Functional Urology) - COI disclosure form
Tet Yap (Design) - COI disclosure form
Consulting Editors
Hashim Uddin Ahmed (Imaging), Anthony Atala (Bio-engineering), Noel Clarke (Translational Science), Matthew Cooperberg (Social Media), Mahesh Desai (Technology), Inderbir Gill (Minimally Invasive Oncology), Mohan Gundeti (Paediatrics), George Hanna (Education), Tim Hunt (Translational Science), Louis Kavoussi (Robotics), Massimo Loda (Translational Science), Stacy Loeb (Cancer and Men’s Health), Graeme MacLennan (Statistics), Casey Ng (Multi-media), Koon Ho Rha (Robotics), Dan Stoianovici (Translational Science), R. Houston Thompson (Oncology)

USANZ Associate Editor
Nathan Lawrentschuk 

网友投稿经验整理:
时间慢!审稿2个月!
贡献者: 219.139.247.105
审稿时间:约1个月    接收率:约25%     
一篇letter,一周接收
贡献者:
审稿时间:约1个月    接收率:约25%     
现在BJU越来越难发表了
贡献者:yhx777
他的网络版算不算SCI,怎么在PUBMED都不收录,估计不算呀。
贡献者:淡淡的
稿件要求越来越高!审了两个多月,还是被拒掉了!
贡献者:122.205.27.75

扫描二维码
关注Pubsci微信
微信公共账号:pubsci888

关键词:论文翻译润色,论文评估,SCI投稿,SCI期刊发表,医生出国进修